Veru Inc is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of diseases, particularly in the areas of oncology and urology. The company is engaged in the research and development of novel drug candidates aimed at addressing unmet medical needs, with a strong emphasis on advancing therapies for prostate cancer and other challenging health conditions. Veru is also involved in the production of specialty pharmaceutical products, showcasing its commitment to improving patient outcomes through scientific innovation and rigorous clinical trials. Read More
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
